The antibody 34bE12, available from A Menarini Diagnostics, recognises cytokeratin 1, 5, 10 and 14. It reacts with squamous and adenosquamous cell carcinomas, while adenocarcinoma is negative. In normal tissue, 34bE12 stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchus. Thus, it is useful as a differential marker for squamous carcinoma and adenocarcinoma as well as for benign and malignant tumours of the prostate gland.
Other News
Latest Issues
The laboratory business is under pressure to change. Market consolidation, standardisation, advanced automation, genomic testing, and the increase in point-of-care testing are driving major shifts in where, when, and how testing takes place. To not only survive, but to thrive, laboratories need a new generation of informatics solutions with...
Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo
Hyatt Regency, Vancouver, Canada
19-23 November, 2024
11th Digital Pathology & AI Congress: Europe
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024
Microbiology Society Annual Conference 2025
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
BSMT Annual Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Ghent Pathology 2025
ICC Ghent, Belgium
24-26 June, 2025